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ABSTRACT
The encephalomyocarditis virus (EMCV) can cause acute myocarditis in young pigs or reproductive 
failure in sows. Diseases caused by EMCV currently affect the swine industry worldwide. In this study, a 
nano polymerase chain reaction (nanoPCR) assay, targeting the 3D gene of EMCV, was developed and its 
sensitivities and specifi cities were investigated. The results indicated that the nanoPCR assay is highly sensitive 
and able to detect 1.2×102 copies/μL of EMCV RNA, as no cross-reaction was observed with other viruses. 
This is the fi rst report to demonstrate the application of a nanoPCR assay for the detection of EMCV. The 
sensitive, and specifi c nanoPCR assay developed in this study can be applied widely in clinical diagnosis and 
fi eld surveillance of EMCV-infection.
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Introduction 
The encephalomyocarditis virus (EMCV) is a member of the genus Cardiovirus of 
the family Picornaviridae, and has worldwide distribution (MINOR et al., 1995). The virus 
was fi rst isolated from pigs in Panama in 1958 (MURNANE et al.,1960), and EMCV has 
been recognized worldwide as a pathogen that can infect several host species, including 
pigs, rodents, cattle, elephants, raccoons, marsupials, and primates, such as baboons, 
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monkeys, chimpanzees, and even humans (AN et al., 2009; GELMETTI et al., 2006; 
KRYLOVA and DZHIKIDZE, 2005; SPYROU et al., 2004). For pigs, EMCV isolates induce 
myocardial or reproductive failure, or both (KOENEN and VANDERHALLEN, 1997). In 
China, EMCV infection has been confi rmed in several pig farms by etiology and serology 
(GE et al., 2010; LIN et al., 2012; YUAN et al., 2014a). 
The current methods of detecting EMCV include virus isolation, serology, reverse 
transcription-polymerase chain reaction (RT-PCR), reverse transcription loop-mediated 
isothermal amplifi cation (RT-LAMP), and TaqMan-based real-time RT-PCR (GE et al., 
2007; JIA et al., 2008; YUAN et al., 2014b; YUAN et al., 2014c). No nanoPCR assay, however, 
has been developed for EMCV. Relative to the conventional PCR assay, a nanoPCR assay 
has the potential for increased sensitivity and specifi city. NanoPCR is an advanced form 
of conventional PCR in which solid gold nanometal particles (1-100 nm) form colloidal 
nanofl uids, which increase thermal conductivity. Therefore, PCR assays with nanofl uids 
reach the target temperature more quickly than PCR assays with original liquids, and this 
reduces the time at non-target temperatures, thereby reducing non-specifi c amplifi cation 
and increasing specifi c amplifi cation (LI and ROTHBERG, 2004; SHEN et al., 2009). In 
addition, the nanoPCR assay does not require specialized instruments beyond standard 
PCR equipment (MA et al., 2013).
In this study, we developed a highly sensitive and specifi c nanoPCR method to target 
the 3D gene for the rapid detection of EMCV in clinical specimens.
Materials and methods
Virus and sample preparation. The EMCV BD2 strain used for the study was isolated 
and identifi ed in the author’s laboratory (YUAN et al., 2014a). BHK-21 cells used for 
virus propagation were maintained in GIBCOTM Dulbecco’s Modifi ed Eagle Medium 
(DMEM) (Invitrogen, Auckland, NY), supplemented with 10 % fetal bovine serum (FBS; 
Hyclone Laboratories Inc., South Logan, UT) at 37 ºC under 5 % CO2. The Nano PCR Kit 
(NPK02) was purchased from GREDBIO (Weihai, China)
Design of primers. The genome of EMCV consists of a large open reading frame 
(ORF). The 3D gene is highly conserved. Primers were selected and designed from the 
conserved 3D gene, using Primer premier 5 software to generate a 425 bp amplicon 
(Table 1). 
Table 1．Primers used in nanoPCR assay for Encephalomyocarditis Virus
Type Sequence (5’-3’) Positiona
Forward CAG AGG CTG ATG TAG ATG AAG TGG C 6357-6381
Reverse CAG AAT GCA ATG CTC AAA TGG TGG A 6757-6781
aNumbers represents the nucleotide position within the genome of BD2 (GenBank accession number: 
KF709977.1)
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RNA extraction. Viral RNA was extracted from 150 μL of supernatant from virus-
infected BHK-21 cells or tissue samples, using the RNA extraction kit (Qiagen Inc., 
USA) following the manufacturer’s instructions. The extracts were resuspended in 20 
μL of distilled water, aliquoted and stored at -80 ºC before nanoPCR amplifi cation was 
carried out. 
NanoPCR assay. The RNA was extracted as described above. RNA was used as a 
template and serially diluted 10-fold in 10 mM Tris-EDTA buffer (pH 8.0) to produce 
5.7 to 5.7×10-6 ng/μL. The NanoPCR assay was performed using EMCV-specifi c primers 
(Table 1). Briefl y, 11 uL RNA extracted from either virus stocks or clinical samples was 
transcribed into cDNA, using 1 μL (10 μM) of P2 (5’-CAG AAT GCA ATG CTC AAA 
TGG TGG A-3’) primer in a 20-μL reaction volume. The reverse transcription (RT) 
reaction was performed at 42 ºC for 50 min. The cDNA was amplifi ed in a 25 μL reaction 
mixture containing 1 μL cDNA, 12.5 μL nanoPCR Mixture (GREDBIO, Weihai, China), 
0.5 μL Taq DNA polymerase (GREDBIO, Weihai, China), and 10 μM each of forward 
and reverse primers by following the manufacturer’s protocol, with the following cycling 
times and temperatures: 94 ºC for 3 min and 30 cycles of 94 ºC for 30 sec, 56 ºC for 30 
sec, and 72 ºC for 25 sec. Five microliters of nanoPCR product was analyzed by agarose 
gel electrophoresis and subjected subsequently to automated sequencing reactions 
(Invitrogen, Beijing, China).
Sensitivity of nanoPCR. To examine the sensitivity of nanoPCR for EMCV 
amplifi cation, RT-PCR, and nanoPCR reaction were conducted using various 
concentrations of EMCV RNA as template. The RNA was quantifi ed by NanoDrop 1000 
(Thermo Scientifi c, USA) and was diluted serially 10-fold from 1.2×107 to 1.2×101 copies/
μL as template for the two methods. NanoPCR were performed using the optimized 
reaction parameters. RT-PCR was performed using the same primers and reaction 
parameters as nanoPCR. Five microliters of RT-PCR products were analyzed by agarose 
gel electrophoresis. The size of the EMCV fragment amplifi ed by RT-PCR was 425 bp.
Specifi ty of nanoPCR. Reactions with different viruses, including EMCV, classical 
swine fever virus (CSFV), porcine enterovirus (PEV), porcine reproductive and 
respiratory syndrome virus (PRRSV), porcine teschovirus (PTV), and porcine epidemic 
diarrhea virus (PEDV) were performed to determine the specifi city of the nanoPCR assay. 
PEV, PRRSV, PTV, and PEDV were identifi ed by our laboratory. CSFV was purchased 
from the Chinese preservation center for veterinary microorganisms.
Clinical specimens. Clinical specimens were collected from different pig farms in the 
Hebei province. The samples included sera, and the tonsils of diseased pigs. Collecting 
clinical specimens met the International Guiding Principles for Biomedical Research 
Involving Animals. Tissue samples were homogenized and centrifuged at 4000×g for 15 
min to obtain a cell-free supernatant. The sample RNAs were extracted as described in 
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the section “RNA extraction”. The nanoPCR were performed as described in the section 
“NanoPCR assay”. Conventional PCR was preformed simultaneously.
Results 
The optimization of the nanoPCR reaction was performed by evaluating different 
concentrations of components and cycling conditions using the EMCV BD2 strain. 
Primers were titrated to determine optimum concentrations, and different annealing 
and data acquisition temperatures were also evaluated (data not shown). The optimized 
reaction parameters are given in Table 2. With these parameters, EMCV RNA was 
amplifi ed adequately by nanoPCR (Fig. 1). The sequence analysis showed high similarity 
(100 %) between the products obtained with the nanoPCR amplifi cation of the 3D gene 
of EMCV (the objective sequences) and the reference sequence of EMCV. The results 
indicated that the nanoPCR method for the detection of EMCV is specifi c.
Fig. 1. Data graph of the nanoPCR assay for EMCV detection. M: DL2000; Lane 1: EMCV; Lane 
2: negative control
Table 2. Optimized parameters for nanoPCR reaction
Component (concentration) Volume (μL ) per 25 μL reaction
nanoPCR Mixture (2×) 12.5
Forward primer (10 μm) 1.0
Reverse primer (10 μm) 1.0
cDNA/DNA 2.0
Taq DNA polymerase (5 U/μL ) 0.5
dd H2O 8.0
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The sensitivity of nanoPCR assay was evaluated by testing 10-fold serial dilution 
of RNA templates (1.2×107 to 1.2×101 copies/μL). The detection limit of nanoPCR was 
1.2×102 copies/μL, whereas that of RT-PCR was 1.2×104 copies/μL (Fig. 2). Comparisons 
between the nanoPCR and RT-PCR amplifi cations indicated that nanoPCR is 100-fold 
more sensitive than RT-PCR. The specifi city of the nanoPCR assay was evaluated using 
other animal viruses, and a water negative control. The nanoPCR assay amplifi ed EMCV 
but none of the other viruses (Fig. 3).
Fig. 2. The sensitivities of nanoPCR and RT-PCR assays. Serial 10-fold dilution of EMCV 
RNA derived from BD2 strain was used in the nanoPCR and RT-PCR assays. (A) Analysis of 
nanoPCR assay by agarose gel electrophoresis. (B) Analysis of the RT-PCR assay by agarose 
gel electrophoresis. M: DL2000; Lane 1: 1.2×107copies/μL; Lane 2: 1.2×106copies/μL; Lane 3: 
1.2×105copies/μL; Lane 4: 1.2×104copies/μL; Lane 5: 1.2×103copies/μL; Lane 6: 1.2×102copies/
μL; Lane 7: 1.2×101copies/μL. All experiments were repeated three times and similar results were 
obtained.
Fig. 3. Specifi c evaluation of the nanoPCR assay for the detection of EMCV. The specifi city of 
the EMCV nanoPCR assay was determined by testing EMCV and fi ve other viruses including 
PRRSV, PEV, CSFV, PTV, and PEDV. The control reaction using DEPC-treated water as template 
was also included. M: DL2000; Lane 1: PRRSV; Lane 2: PEV; Lane 3: CSFV; Lane 4: PTV; Lane 
5: PEDV; Lane 6: negative control. 
NanoPCR assay and conventional PCR were preformed simultaneously on 100 
clinical samples. The results are shown in Table 3. Eight of 100 samples (8 %) were 
positive by RT-PCR analysis, whereas 13 of 100 samples (13 %) were positive by 
nanoPCR (Table 2). Eight samples (8 %) were positive by both methods. Five samples (5 
%) were positive by nanoPCR, but negative by RT-PCR. No sample (0 %) was positive by 
RT-PCR and negative by nanoPCR. The results showed that nanoPCR was more sensitive 
than the conventional RT-PCR assay.
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Table 3． Comparison of nanoPCR and RT-PCR assays for detection of Encephalomyocarditis 
Virus from clinical samples
Animal Type of tissue or samples







EMCV can cause acute myocarditis in young pigs or reproductive failure in sows. 
Serological studies have shown the presence of EMCV antibodies in the human population 
(OBERSTE et al., 2009). It was demonstrated that an EMCV strain, isolated from an aborted 
swine fetus, productively infected human cardiomyocytes in vitro (BREWER et al., 2001). 
The signifi cance for public health of EMCV is also worthy of concern. 
The current methods for detecting EMCV include virus isolation, serology, reverse 
RT-PCR, RT-LAMP, and TaqMan-based real-time RT-PCR (GE et al., 2007; JIA et al., 
2008; YUAN et al., 2014b; YUAN et al., 2014c). Virus isolation is one of the conventional 
methods, but it is time-consuming and laborious. Serology is the technique used most 
widely, however, this method has some disadvantages because antibody titers can fall 
rapidly after infection. In addition, real-time PCR assays require expensive instruments, 
and LAMP assays are easily contaminated. NanoPCR is an advanced form of PCR 
in which solid gold nanometal particles (1-100 nm) form colloidal nanofl uids, which 
increase thermal conductivity. Therefore, PCR assays with nanofl uids reach the target 
temperature more quickly than PCR assays with original liquids, reducing the time at non-
target temperatures, thereby reducing non-specifi c amplifi cation and increasing specifi c 
amplifi cation (LI and ROTHBERG, 2004; SHEN et al., 2009). In addition, the nanoPCR 
assay does not require specialized instruments beyond standard PCR equipment (MA 
et al., 2013). The nanoPCR assay has been used in detecting viral RNA molecules from 
animals due to its simplicity and high sensitivity, including pseudorabies (MA et al., 2013), 
and porcine bocavirus (WANG et al., 2014).
In this study, a highly effi cient and practical method for the detection of EMCV was 
established. Since the 3D gene of EMCV is among the most conserved regions and has 
been chosen as a preferred target region for the detection of EMCV RNA by RT-PCR 
(JIA et al., 2008; YUAN et al., 2014b), primers were designed to amplify target sequences 
at the 3D gene region of the EMCV genome for nanoPCR assay. The nanoPCR assay 
is highly sensitive and able to detect 1.2×102 copies/μL of EMCV RNA, as no cross-
reaction was observed with other viruses. The sensitivity of nanoPCR for EMCV was 
100-fold greater than RT-PCR. This is the fi rst report to demonstrate the application of a 
nanoPCR amplifi cation technique for the detection of EMCV.
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SAŽETAK 
Virus encefalomiokarditisa može uzrokovati akutni miokarditis u prasadi ili reprodukcijske poremećaje u 
krmača. Poremećaji uzrokovani virusom encefalomiokarditisa prošireni su u svinja u industrijskoj proizvodnji 
diljem svijeta. U ovom je istraživanju razvijena nano-lančana reakcija polimerazom (nanoPCR) za dokaz gena 
3D virusa encefalomiokarditisa te je istražena njezina osjetljivost i specifi čnost. Rezultati su pokazali da je 
nanoPCR visoko osjetljiva metoda kojom se može dokazati 1,2×102 kopija RNA virusa encefalomiokarditisa na 
μL te da nisu dokazane križne reakcije s drugim virusima. Ovo je prvo izvješće u kojem je dokazana primjena 
nanoPCR-a za dokaz virusa encefalomiokarditisa. Njezina osjetljivost i specifi čnost upućuju na zaključak da se 
može naširoko rabiti u kliničkoj dijagnostici i terenskim istraživanjima encefalomiokarditisa svinja.
Ključne riječi: virus encefalomiokarditisa, nanoPCR, RT-PCR _______________________________________________________________________________________
